Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

Justin J. Kennedy leads new Programme in Personal Excellence
2012-05-08

 

Justin J. Kennedy
Photo: Leatitia Pienaar
8 May 2012

Justin J. Kennedy has been appointed as the Manager of the new Programme in Personal Excellence. The programme is hosted in the Centre for Business Dynamics, the commercial unit of the Business School.

He studied at Rhodes University and the University of the Western Cape (UWC) and his research has been published in various health-related publications. His D.Psych. at the University of California migrated into a Ph.D. with research partner DiscoveryHealth.

While in New York, he was part of the research laboratory Helicor that developed the world’s first hand-held medical device for measuring heart-rate variability of the peripheral nervous system.  This device forms part of the programmes offered to control stress and improve cognitive performance as per clinical trials at the UCT Department of Human Biology. This programme evolved into developing the M.Sc. course work on occupational stress and Ph.D. student supervision.

The programme will launch during the university's Beneficiary Programme for Academic Heads of Department, and will focus on the neuro-economics of stress resilience.

Justin’s most recent research is peer review for an international leadership journal where he has presented evidence on how people can improve their cognitive performance and working memory by building functional stress resilience. The overall aim of the programme is to not only reduce stress, but to improve ability to be excellent at work.  Clinical results have shown it is beneficial for performance anxiety, insomnia, migraine, hypertension control and improved ability at cognitive tasks.  The aim of his work is to ensure that simple and practical skills provide academics, students and corporate participants with enduring, functional techniques that are easily applied in their working lives.

The programme has three roles: to offer services that equip students and academics; consulting services to corporate clients, financial groups and private hospitals; and publication of results in peer-reviewed journals. 

This initiative also envisages offering a postgraduate qualification and selected coaching qualifications.  For more info about corporate interventions and programmes open to students and academics, please contact Ansie Barnard at barnardam@ufs.ac.za.
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept